Pendal Group LTD Astrazeneca PLC Transaction History

Pendal Group LTD

$12.2 Billion
Q4 2022

A detailed history of Pendal Group LTD transactions in Astrazeneca PLC stock. As of the latest transaction made, Pendal Group LTD holds 5,504 shares of AZN stock, worth $398,269. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,504

Previous 5,525 0.38%

Holding current value

$398,269

Previous $303,000 23.1%

% of portfolio

0.0%

Previous 0.0%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 19, 2023	SELL	$54.21 - $70.44 $1,138 - $1,479	-21 Reduced 0.38%	5,504 $0
Q3 2022 Oct 18, 2022	SELL	$53.02 - $135.75 $2,651 - $6,787	-50 Reduced 0.9%	5,525 $303,000
Q2 2022 Jul 25, 2022	SELL	$59.26 - $71.14 $431,946 - $518,539	-7,289 Reduced 56.66%	5,575 $368,000
Q1 2022 Apr 25, 2022	SELL	$55.72 - $67.12 $26,689 - $32,150	-479 Reduced 3.59%	12,864 $853,000
Q4 2021 Jan 18, 2022	SELL	$54.02 - $63.83 $56,504 - $66,766	-1,046 Reduced 7.27%	13,343 $777,000
Q3 2021 Nov 05, 2021	BUY	$55.56 - $60.79 $799,452 - $874,707	14,389 New	14,389 $864,000

Others Institutions Holding AZN

# of Institutions

1,336

Shares Held

477M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $224B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pendal Group LTD with notifications on news.

Account